Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Von Willebrand factor abnormalities in IgA nephropathy

G Bertaglia1, E Ossi, A Casonato

  • 1Institute of Internal Medicine, School of Medicine, University of Padua, Italy.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
|March 1, 1997
PubMed
Summary

This study found altered von Willebrand factor (vWF) in IgA nephropathy (IgAN) patients, including large vWF multimers, suggesting unique vWF handling in IgAN compared to other glomerulonephritis types.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A framework for the optimal design of a minimum set of clinical trials to characterize von Willebrand disease.

Computer methods and programs in biomedicine·2019
Same author

Type 2N von Willebrand disease: Characterization and diagnostic difficulties.

Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same author

Usefulness of the Total Thrombus-Formation Analysis System (T-TAS) in the diagnosis and characterization of von Willebrand disease.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Severe, recessive type 1 is a discrete form of von Willebrand disease: the lesson learned from the c.1534-3C>A von Willebrand factor mutation.

Thrombosis research·2015
Same author

Is EU/EEA population protected from polio?

Human vaccines & immunotherapeutics·2015
Same author

Loss of cysteine 584 impairs the storage and release, but not the synthesis of von Willebrand factor.

Thrombosis and haemostasis·2014

Area of Science:

  • Nephrology
  • Vascular Biology
  • Immunology

Background:

  • Plasma von Willebrand factor (vWF) is an indicator of endothelial dysfunction.
  • Abnormal vWF levels and unusually large vWF multimers are implicated in microangiopathic diseases and glomerulonephritis.
  • Qualitative vWF analysis in IgA nephropathy (IgAN) and proliferative glomerulonephritis (PGN) is lacking.

Purpose of the Study:

  • To quantitatively and qualitatively analyze vWF in IgAN and PGN patients.
  • To investigate potential differences in vWF characteristics between IgAN and PGN.

Main Methods:

  • Studied vWF parameters in 14 IgAN patients, 8 PGN patients, 7 other glomerulonephritis patients, and 10 healthy controls.
  • Measured vWF antigenic activity (vWF:Ag) using electroimmunodiffusion.

Related Experiment Videos

  • Analyzed vWF mobility and multimeric patterns using crossed immunoelectrophoresis (CIE) and SDS-agarose gel electrophoresis.

    • Main Results:

    • Mean vWF:Ag was significantly higher in PGN patients versus controls.
    • A vWF 'pre-peak' was observed in 12/14 IgAN patients but not in PGN patients.
    • Abnormally large vWF multimers were found in 4 IgAN patients, but not in PGN patients.

    Conclusions:

    • The presence of a vWF pre-peak and large multimers in IgAN suggests altered postsecretory vWF handling.
    • vWF may play a different role in IgAN pathogenesis compared to PGN.
    • Findings highlight distinct vWF characteristics in IgAN.